We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+30.54%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$11.5B
AUM Growth
+$3.09B
(+37%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
9.43%
Holding
1,665
New
559
Increased
260
Reduced
246
Closed
589
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$91.6M |
| 2 |
Abbott
ABT
|
+$75M |
| 3 |
FISV
Fiserv Inc
FISV
|
+$74.8M |
| 4 |
JPMorgan Chase
JPM
|
+$69.6M |
| 5 |
Alibaba
BABA
|
+$68.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lowe's Companies
LOW
|
+$96.4M |
| 2 |
AGN
Allergan plc
AGN
|
+$92.4M |
| 3 |
Johnson Controls International
JCI
|
+$76.9M |
| 4 |
Dollar General
DG
|
+$76.8M |
| 5 |
Boston Scientific
BSX
|
+$73.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.44% |
| 2 | Consumer Discretionary | 13.08% |
| 3 | Financials | 11.26% |
| 4 | Industrials | 10.99% |
| 5 | Healthcare | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVO
476
DELISTED
Meridian Bioscience Inc
VIVO
| $5.9M | 0.05% |
253,273
+52,686
| +26% | +$764K |
|
477
Webster Financial
WBS
$12.8B
| $5.89M | 0.05% |
205,744
+144,627
| +237% | +$3.83M |
|
478
Red Robin
RRGB
$150M
| $5.87M | 0.05% |
+575,721
| New | +$7.25M |
|
|
DNKN
479
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $5.84M | 0.05% |
89,489
-132,505
| -60% | -$8.25M |
|
480
State Street Financial Select Sector SPDR ETF
XLF
$59B
| $5.82M | 0.05% |
251,589
-1,419,476
| -85% | -$32.2M |
|
481
Travelers Companies
TRV
$78.3B
| $5.82M | 0.05% |
50,991
-198,287
| -80% | -$20.9M |
|
|
TWOU
482
DELISTED
2U Inc
TWOU
| $5.79M | 0.05% |
5,088
-6,349
| -56% | -$5.67M |
|
483
Artisan Partners
APAM
$3B
| $5.7M | 0.05% |
175,418
+114,838
| +190% | +$3.18M |
|
484
PUT
Intuitive Surgical
ISRG
$139B
| $5.7M | 0.05% |
30,000
-67,500
| -69% | -$12.1M |
|
|
NATI
485
DELISTED
National Instruments Corp
NATI
| $5.65M | 0.05% |
146,007
-104,480
| -42% | -$3.95M |
|
486
Rayonier
RYN
$6.52B
| $5.64M | 0.05% |
+250,979
| New | +$5.46M |
|
|
DOCU
487
DocuSign
DOCU
$11.4B
| $5.64M | 0.05% |
+32,754
| New | +$4.13M |
|
488
Pool Corp
POOL
$7.27B
| $5.61M | 0.05% |
20,646
-32,409
| -61% | -$7.5M |
|
|
ALXN
489
CALL
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.61M | 0.05% |
50,000
| – | – |
|
|
AXNX
490
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.58M | 0.05% |
+159,024
| New | +$5.48M |
|
491
CALL
Walt Disney
DIS
$178B
| $5.58M | 0.05% |
+50,000
| New | +$5.52M |
|
492
STMicroelectronics
STM
$48.5B
| $5.51M | 0.05% |
201,187
+177,842
| +762% | +$4.42M |
|
493
CALL
Healthpeak Properties
DOC
$14.4B
| $5.51M | 0.05% |
+200,000
| New | +$5.11M |
|
494
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $5.5M | 0.05% |
+17,836
| New | +$5.22M |
|
495
CALL
Align Technology
ALGN
$12.5B
| $5.49M | 0.05% |
+20,000
| New | +$4.5M |
|
496
CALL
Sysco
SYY
$40.1B
| $5.47M | 0.05% |
+100,000
| New | +$5.26M |
|
497
Honeywell
HON
$77B
| $5.44M | 0.05% |
+39,897
| New | +$5.28M |
|
|
GLIBA
498
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
| $5.42M | 0.05% |
76,168
+72,220
| +1,829% | +$4.63M |
|
499
B&G Foods
BGS
$276M
| $5.38M | 0.05% |
+220,820
| New | +$4.78M |
|
500
MaxLinear
MXL
$6.21B
| $5.38M | 0.05% |
250,641
+223,891
| +837% | +$3.86M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q2 2020 Portfolio in Review
As of Q2 2020, Balyasny Asset Management held 1,665 positions worth $11.5B, up 37% from $8.43B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.
Balyasny Asset Management deployed $1.48B of net new capital in Q2 2020, opening 559 new positions and adding to 260 existing holdings. Its largest new stake was Charles Schwab: 2,556,974 shares worth $86.3M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Lowe's Companies, an estimated $96.4M trimmed.
- Balyasny Asset Management's largest Q2 2020 buy was Charles Schwab: 2,556,974 shares worth $86.3M.
- Balyasny Asset Management added most to Fiserv Inc in Q2 2020, an estimated $74.8M increase.
- Balyasny Asset Management's biggest Q2 2020 reduction was Lowe's Companies, cutting an estimated $96.4M.
- Balyasny Asset Management fully exited Allergan plc in Q2 2020, selling an estimated $92.4M.
- Balyasny Asset Management's ten largest holdings make up 9.4% of its $11.5B portfolio in Q2 2020.
- Balyasny Asset Management opened 559 new positions and closed 589 in Q2 2020.
- Balyasny Asset Management's portfolio value rose 37% quarter-over-quarter to $11.5B.
Based on Balyasny Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.